Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | N/A | -43,108 |
| Depreciation Amortization | N/A | 527 |
| Accounts payable and accrued liabilities | N/A | 914 |
| Other Working Capital | N/A | 128,920 |
| Other Operating Activity | 0 | 883 |
| Operating Cash Flow | $N/A | $88,136 |
| Cash Flows From Investing Activities | ||
| PPE Investments | N/A | -650 |
| Purchase Of Investment | N/A | -101,943 |
| Sale Of Investment | N/A | 16,337 |
| Investing Cash Flow | $N/A | $-86,256 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | N/A | 11 |
| Other Financing Activity | 0 | 80,934 |
| Financing Cash Flow | $N/A | $80,945 |
| Beginning Cash Position | N/A | 25,168 |
| End Cash Position | N/A | 107,993 |
| Net Cash Flow | $N/A | $82,825 |
| Free Cash Flow | ||
| Operating Cash Flow | N/A | 88,136 |
| Capital Expenditure | N/A | -650 |
| Free Cash Flow | 0 | 87,486 |